Top compounds associated with response to CTD-2545G14.7


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA azacitidine CTRPv2 pan-cancer AAC -0.084 0.03
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.03
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.16 0.03
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.076 0.03
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV